Genesis Biotechnology Group® (GBG) is a consortium of vertically integrated companies with a mission of improving patient care by cross-linking their expertise, dedication, and vision in drug discovery, personalized and tailored clinical diagnostics and the development of unique biotechnology-based products. Through the consolidation of research activities in the fields of biotechnology, molecular biology, genome research, biochemistry and biophysics, bioinformatics and computer science, we are able to cultivate research partnerships between highly productive research teams that break through the barriers of traditional disciplinary boundaries.
GBG is located in the “Einstein Alley” section of Hamilton Township, NJ. The campus is easily accessible to universities, pharmaceutical companies, research institutes, and hospitals in the New York, New Jersey, and Pennsylvania area. GBG is comprised of clinical research, medicinal chemistry and biological laboratories, office and conference areas occupying over 250,000 square feet.
This concentration of diverse groups of scientists with experience in molecular biology, genetics, protein purification and expression, molecular modeling, high throughput screening (HTS), and medicinal chemistry, enable us to create and sustain a complex research platform in areas such as cancer drug discovery, and the design of surrogate biomarkers for chronic complex illnesses.